Feinberg M - Search Results

1

HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons.

Harrer E, Harrer T, Buchbinder S, Mann DL, Feinberg M, Yilma T, Johnson RP, Walker BD. Harrer E, et al. Among authors: feinberg m. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S77-8. AIDS Res Hum Retroviruses. 1994. PMID: 7532426 No abstract available.

2

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

Harrer E, Harrer T, Barbosa P, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer E, et al. Among authors: feinberg m. J Infect Dis. 1996 Feb;173(2):476-9. doi: 10.1093/infdis/173.2.476. J Infect Dis. 1996. PMID: 8568316

3

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: feinberg mb. AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585. AIDS Res Hum Retroviruses. 1996. PMID: 8743084

4

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: feinberg mb. J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327

5

Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.

Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer T, et al. Among authors: feinberg m. J Immunol. 1998 Nov 1;161(9):4875-81. J Immunol. 1998. PMID: 9794421

6

Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.

Kaur A, Grant RM, Means RE, McClure H, Feinberg M, Johnson RP. Kaur A, et al. Among authors: feinberg m. J Virol. 1998 Dec;72(12):9597-611. doi: 10.1128/JVI.72.12.9597-9611.1998. J Virol. 1998. PMID: 9811693 Free PMC article.

7

Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection.

Kaur A, Alexander L, Staprans SI, Denekamp L, Hale CL, McClure HM, Feinberg MB, Desrosiers RC, Johnson RP. Kaur A, et al. Among authors: feinberg mb. Eur J Immunol. 2001 Nov;31(11):3207-17. doi: 10.1002/1521-4141(200111)31:11<3207::aid-immu3207>3.0.co;2-h. Eur J Immunol. 2001. PMID: 11745337 Free article.

8

Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys.

Sodora DL, Douek DC, Silvestri G, Montgomery L, Rosenzweig M, Igarashi T, Bernacky B, Johnson RP, Feinberg MB, Martin MA, Koup RA. Sodora DL, et al. Among authors: feinberg mb. Eur J Immunol. 2000 Apr;30(4):1145-53. doi: 10.1002/(SICI)1521-4141(200004)30:4<1145::AID-IMMU1145>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 10760804 Free article.

9

The complex challenges of HIV vaccine development require renewed and expanded global commitment.

Bekker LG, Tatoud R, Dabis F, Feinberg M, Kaleebu P, Marovich M, Ndung'u T, Russell N, Johnson J, Luba M, Fauci AS, Morris L, Pantaleo G, Buchbinder S, Gray G, Vekemans J, Kim JH, Levy Y, Corey L, Shattock R, Makanga M, Williamson C, Dieffenbach C, Goodenow MM, Shao Y, Staprans S, Warren M, Johnston MI. Bekker LG, et al. Among authors: feinberg m. Lancet. 2020 Feb 1;395(10221):384-388. doi: 10.1016/S0140-6736(19)32682-0. Epub 2019 Dec 2. Lancet. 2020. PMID: 31806257 Review. No abstract available.

10

Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, Mogg R, DiNubile MJ, Shiver JW, Leavitt RY, Robertson MN, Mehrotra DV, Quirk E; Merck V520-016 Study Group. Priddy FH, et al. Clin Infect Dis. 2008 Jun 1;46(11):1769-81. doi: 10.1086/587993. Clin Infect Dis. 2008. PMID: 18433307 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

846 results

Search Page

Filters